Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 19, 2020

BUY
$41.6 - $63.4 $8,528 - $12,997
205 New
205 $10,000
Q1 2019

Apr 30, 2019

SELL
$52.92 - $81.17 $10,848 - $16,639
-205 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$45.56 - $59.57 $9,339 - $12,211
205
205 $10,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Perennial Advisors, LLC Portfolio

Follow Perennial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Advisors, LLC with notifications on news.